(Q33759380)

29 July 2017

1 reference

title

Micronized fenofibrate: a new fibric acid hypolipidemic agent (English)

1 reference

29 July 2017

D R Guay

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

Annals of Pharmacotherapy

29 July 2017

published in

1 reference

29 July 2017

volume

33

1 reference

29 July 2017

issue

10

1 reference

29 July 2017

page(s)

1083-1103

1 reference

Choosing the right lipid-regulating agent. A guide to selection

29 July 2017

cites work

1 reference

Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease. Fibrate Consensus Group

21 January 2018

1 reference

Effect of statins on metabolism of apo-B-containing lipoproteins in hypertriglyceridemic men.

21 January 2018

1 reference

Pharmacological control of hypertriglyceridemia.

21 January 2018

1 reference

Statins: is there a need for alternative or adjunctive therapy?

21 January 2018

1 reference

Regulation of Lipoprotein Metabolism by Thiazolidinediones Occurs through a Distinct but Complementary Mechanism Relative to Fibrates

21 January 2018

1 reference

Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates

21 January 2018

1 reference

Fibrates influence the expression of genes involved in lipoprotein metabolism in a tissue-selective manner in the rat

21 January 2018

1 reference

Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice

21 January 2018

1 reference

Down-regulation of hepatic lipase gene expression and activity by fenofibrate

21 January 2018

1 reference

Altered hepatic metabolism of fatty acids in rats fed a hypolipidaemic drug, fenofibrate.

21 January 2018

1 reference

Induction of the peroxisome proliferator activated receptor by fenofibrate in rat liver

21 January 2018

1 reference

Comparative ultrastructural study of rat hepatocytes after treatment with the hypolipidemic agents probucol, clofibrate, and fenofibrate

21 January 2018

1 reference

Treatment of hypercholesterolaemia with fenofibrate: a review

21 January 2018

1 reference

The effects of fibrates on lipoprotein and hemostatic coronary risk factors

21 January 2018

1 reference

Changes in lipoprotein kinetics during therapy with fenofibrate and other fibric acid derivatives

21 January 2018

1 reference

Fibric acids: effects on lipids and lipoprotein metabolism

21 January 2018

1 reference

Structure and biochemical effects of fenofibrate

21 January 2018

1 reference

Pharmacotherapy of disorders of plasma lipoprotein metabolism

21 January 2018

1 reference

Differences in the response of serum lipoproteins to fenofibrate between women and men with primary hypercholesterolaemia.

21 January 2018

1 reference

Effects of fenofibrate on lipids, lipoproteins, and apolipoproteins in 33 subjects with primary hypercholesterolemia.

21 January 2018

1 reference

Effects of fenofibrate on biliary lipids and bile acid pool size in patients with type IV hyperlipoproteinemia

21 January 2018

1 reference

Effects of fenofibrate on angiographically examined coronary atherosclerosis and left ventricular function in hypercholesterolemic patients

21 January 2018

1 reference

Fenofibrate improves postprandial chylomicron clearance in II B hyperlipoproteinemia

21 January 2018

1 reference

Effects of fibric acid derivatives on biliary lipid composition

21 January 2018

1 reference

Effects of fenofibrate on plasma lipoproteins in hypercholesterolemia and combined hyperlipidemia

21 January 2018

1 reference

Fenofibrate affects the compositions of lipoproteins

21 January 2018

1 reference

A multicenter comparison of the effects of simvastatin and fenofibrate therapy in severe primary hypercholesterolemia, with particular emphasis on lipoproteins defined by their apolipoprotein composition

21 January 2018

1 reference

Lipoprotein particle analysis comparing simvastatin and fenofibrate

21 January 2018

1 reference

Efficacy and safety of a new hydroxymethylglutaryl-coenzyme A reductase inhibitor, atorvastatin, in patients with combined hyperlipidemia: comparison with fenofibrate.

21 January 2018

1 reference

Effects of simvastatin and fenofibrate on serum lipoproteins and apolipoproteins in primary hypercholesterolaemia

21 January 2018

1 reference

Safety of fenofibrate--US and worldwide experience

21 January 2018

1 reference

Comparative toxicity and safety profile of fenofibrate and other fibric acid derivatives

21 January 2018

1 reference

Interaction between fenofibrate and warfarin

21 January 2018

1 reference

Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia

21 January 2018

1 reference

A head-to-head comparison of the cost effectiveness of HMG-CoA reductase inhibitors and fibrates in different types of primary hyperlipidemia

21 January 2018

1 reference

Differential induction profile of drug-metabolizing enzymes after treatment with hypolipidaemic agents

21 January 2018

1 reference

Biological variations in hyperlipidemic children and adolescents treated with fenofibrate

21 January 2018

1 reference

Photosensitivity induced by fibric acid derivatives and its relation to photocontact dermatitis to ketoprofen

21 January 2018

1 reference

PHOTODEGRADATION AND in vitro PHOTOTOXICITY OF FENOFIBRATE, A PHOTOSENSITIZING ANTI-HYPEIUIPOPROTEINEMIC DRUG

21 January 2018

1 reference

PHOTOSENSITIZATION BY FENOFIBRATE. II. In vitro PHOTOTOXICITY OF THE MAJOR METABOLITES

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.18432

1 reference

29 July 2017

1 reference